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Background: The positive impact of pulmonary rehabilitation (PR) in patients with COPD is 
well documented. However, little is known regarding the effect of this treatment in community-
based settings. Since 2007, all Danish municipalities have been offering PR to patients with 
moderate to severe COPD, whereas patients with very severe disease or those suffering from 
many comorbidities were referred to outpatient hospital-based PR.
Objective: To analyze the effect of a standardized PR program conducted in a community-
based setting on exercise capacity and health-related quality of life (HRQoL).
Methods: This is a real-life study including data from patients attending PR at one of the 
33 healthcare centers in Denmark during the period 2011–2012. For the purpose of registration 
and for quality assurance, the KOALA database was established and this web-based registration 
instrument was offered free of charge to every municipality. Measures included sociodemo-
graphic and health-related variables and outcomes were exercise capacity and HRQoL assessed 
by 6-minute walking distance (6MWD) and the 15D questionnaire, respectively, at the begin-
ning (baseline) and after completion of PR. Relative improvements in 6MWD and 15D were 
analyzed with multivariable linear models in patients who attended .50% of the sessions.
Results: A total of 581 patients completed the PR (72% of those included). We found statisti-
cally significant and clinically meaningful differences between baseline and end of rehabilitation 
values for both main outcomes with a mean change in 6MWD of 45 m, and the magnitude of 
improvement corresponds to other findings. Furthermore, relative improvements in 6MWD 
and 15D were correlated, as was the relative change in 15D and baseline Medical Research 
Council scores.
Conclusion: Standardized, multidisciplinary PR conducted in a community-based setting 
showed good adherence to the program and produced effects on exercise capacity and HRQoL 
that were clinically meaningful and comparable in size to hospital-based PR.
Keywords: COPD, community-based, exercise capacity, pulmonary rehabilitation, quality 
of life
Introduction
The beneficial effects of hospital-based pulmonary rehabilitation (PR) on exercise 
capacity, perception of dyspnea, and quality of life in patients with moderate to 
very severe COPD have been extensively documented.1,2 According to the Cochrane 
authors, studies comparing PR with usual care are no longer warranted; instead, future 
studies should focus on settings, intensity, and duration of the PR program as well as 
of the achieved effect.1 With respect to the impact of rehabilitation on these outcomes 
in patients with less advanced disease, the evidence is limited, even more so when 
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evaluating the effect of this intervention in a home-based 
or community-based setting.3,4 Most of the studies included 
small sample size, and there was no consensus as to recom-
mended type of training or the duration and maintenance 
of PR in these settings compared with the in- or outpatient 
hospital-based programs. However, one reasonably large 
randomized controlled trial of 199 patients with moderate 
COPD showed that community-based rehabilitation was 
effective in improving exercise performance and quality of 
life and was also cost-effective compared with usual care.5,6 
In this 2-year study, the exacerbation rate did not differ 
between the intervention group and the usual care group. 
A recently published meta-analysis also resulted in a weak 
recommendation for routine PR in patients with perceived 
dyspnea corresponding to modified Medical Research 
Council (mMRC) $1.7
In Denmark, the National Board of Health recommended 
in 2006 that all COPD patients with a dyspnea grade of 3 
or above according to the MRC scale should be offered PR. 
Furthermore, the intention was that patients with mild to 
moderate disease were referred to this service in primary 
care, while patients with severe to very severe COPD 
(GOLD D with frequent exacerbations) were referred to 
hospital-based outpatient clinics.8 Hence, since 2007, all 
98 municipalities in Denmark have gradually implemented 
rehabilitation programs for patients with COPD. To comply 
with this task, many municipalities have established one or 
several healthcare centers with a multidisciplinary staff, 
though usually not including medical doctors. To our 
knowledge, only two studies have compared the effects of 
standardized PR programs conducted either in a healthcare 
center/community site or in a hospital outpatient setting.9,10 
Both studies concluded that the two settings were equally 
effective in terms of improving endurance shuttle walking 
time (ESWT) and quality of life; however, in the Danish 
study, improvement in the ESWT was significantly greater in 
the hospital setting.9 Due to the lack of data registration and 
quality assurance instruments for PR in primary healthcare, 
the KOALA project was launched in 2007 by Boehringer 
Ingelheim Denmark A/S as an opportunity for the newly 
established healthcare centers to enter the data and clini-
cal parameters of participating patients into a Web-based 
database.
The aim of this non-randomized, real-life study was 
to analyze the efficacy of community-based rehabilitation 
programs in a large COPD patient population on exercise 
capacity, measured using the 6-minute walking distance 
(6MWD) test, and health-related quality of life (HRQoL), 
measured using 15D questionnaire, as primary end points.
Methods
The overall purpose and design of the KOALA project has 
previously been described in detail.11
Brief description of the KOala database
The main objective of the KOALA database was to construct 
a digital platform for recording relevant indicators of PR, 
which could be used in healthcare across all municipalities 
in Denmark. Other objectives included implementation of the 
database as a quality assurance instrument and a forum for 
sharing of knowledge and evaluation. The project was orga-
nized with a steering committee consisting of key healthcare 
professionals and a daily manager employed by Boehringer-
Ingelheim. The variables were assessed and measured pre- 
and post-PR and included, among many, demographic and 
behavioral characteristics of the participants, such as medica-
tion for COPD, smoking habits, frequency of exacerbations, 
previous PR, comorbidities, and dyspnea measured as MRC 
and Borg dyspnea scale (BORG). HRQoL was measured 
using a generic 15-item questionnaire 15D, which has proven 
to be valid and reliable in assessing and detecting changes in 
HRQoL in chronic conditions including COPD.12,13 Exercise 
capacity was tested using 6MWD14 and in some centers 
also included the incremental and endurance shuttle walk 
test (SWT), and was recorded at baseline, at completion of 
the PR, and at eventual subsequent follow-up visits. Upon 
completion of the rehabilitation program, relevant clinical 
information was sent electronically via EDIFACT to the 
patients’ general practitioners.
Inclusion of healthcare centers and 
referral of patients
The daily manager of the KOALA project invited healthcare 
centers to participate by face to face meetings preceded by 
e-mail or phone correspondence. The healthcare professionals 
employed by the municipalities are mainly represented by 
specially trained nurses, physiotherapists, and dieticians – 
preferably as a multidisciplinary team – depending on the 
size and facilities in the municipality. However, all patients 
attending COPD rehabilitation must be referred by a doctor 
(general practitioner or pulmonary specialist) based on a 
diagnosis of COPD, a spirometry conducted in less than 
1 year, and assessment of the subject’s degree of dyspnea 
on exertion. Whenever possible, the patient also had his/her 
lung function measured at the healthcare center before 
rehabilitation was started. Although minor deviations exist, 
most healthcare centers have implemented the standard PR 
program with respect to content and duration, ie, focusing on 
aerobic exercise endurance and lasting for 6–12 weeks and 
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in some centers with 1–2 subsequent follow-up visits within 
the following year. All the community-based PR programs in 
Denmark provide supervised aerobic and strength training at 
least twice a week, breathing exercises, and group educational 
sessions comprising, at a minimum, management of dyspnea 
and exacerbations and inhalation technique. If available, 
nutritional support, psychosocial interventions, and home-
training programs were provided. In general, the healthcare 
centers have adopted the Danish outpatient hospital-based 
PR recommendations.15
By February 2011, all 78 municipalities, who at that 
time offered standardized PR in Denmark, were contacted, 
and of these 33 agreed to participate in the KOALA project. 
We report data that were extracted from the database at 
Danish Technical University (DTU) in August 2012.
ethical considerations
All patients provided written consent as it is mandatory 
for participation in PR, and the study was approved by the 
Danish Data Protection Agency. However, ethical approval 
was not indicated due to the non-interventional setting of 
this study.
statistical analyses
In this paper, we present results from the changes recorded 
during rehabilitation, ie, the difference between the first 
(baseline) visit and at the end of the rehabilitation program. 
Categorical variables were summarized by frequency and per-
centage. Continuous variables were summarized by median 
and interquartile range (IQR) as the data were not normally 
distributed. The improvement in the two primary outcomes 
of interest, 6MWD and 15D, was tested univariately by 
Wilcoxon signed-rank test for paired observations.
Factors associated with the relative improvement in 
6MWD/15D were analyzed in a multivariable linear regres-
sion model. For continuous factors, the association with 
the relative improvement was estimated by restricted cubic 
splines (non-parametric smooth functions) and the effect 
reported as the effect corresponding to interquartile range 
increases. The association between the relative improvement 
in 15D and the initial score and the association between abso-
lute changes in 6MWD and 15D were tested by Spearman 
correlation coefficients and corresponding P-values.
The statistical analyses were performed using the sta-
tistical software R version 2.11.1 (R Development Core 
Team [2009]). R: A language and environment for statistical 
computing. R Foundation for Statistical Computing, Vienna, 
Austria. ISBN 3-900051-07-0, URL http://www.R-project.
org.), and a 5% significance level was used in all tests.
Results
The results from this study are based on data from 33 partici-
pating centers and included patients that were referred and 
participated in PR between October 2011 and August 2012. 
A total of 803 COPD patients were included in the study, 
and at the time of analysis 581 patients completed the full 
rehabilitation program (.50% attendance) with pre- and 
post-rehabilitation data. The rehabilitation period was 
64 days (median).
Demographic data including assessment of comor-
bidities for patients completing rehabilitation program are 
shown in Table 1. The majority of patients had moderate 
disease severity according to GOLD criteria, however, 
with median FEV
1
 only just above 50% of expected and 
Table 1 Baseline characteristics of the patients
Baseline data for patients 
completing PR (n=581)
Median (IQR)/N (%)
gender
Female 58.4%
Male 41.7%
age (years) 68.1 (11.1)
FeV1 (% pred) 53.5% (25.2)
COPD stage (gOlD 2007)
Mild 4.7%
Moderate 45.8%
severe 25.7%
Very severe 6.7%
Missing information 17.2%
MrC
1 6.9%
2 33.6%
3 43.7%
4 11.4%
5 3.6%
Missing information 2.4%
Pack-years 37.5 (24.0)
BMI (kg/m2) 25.7 (7.2)
smoking status
never 4.1%
ex 67.5%
Current 27.9%
Missing information 0.5%
Osteoporosis 9.3%
heart disease 20.1%
Depression 11.9%
Diabetes 9.1%
Abbreviations: BMI, body mass index; MrC, Medical research Council; Pr, pulm-
onary rehabilitation.
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moderate degree of dyspnea. Overall, the prevalence of 
comorbidities was low with cardiovascular disease being 
the most frequent.
Key parameters for effect of rehabilitation showed sig-
nificant and clinically meaningful changes as displayed in 
Tables 2 and 3 for 6MWD and 15D, respectively. 6MWD 
improved by an average of 45m (P,0.001) and the change 
was significant across COPD stage groups. Furthermore, look-
ing at quartiles of 6MWD based on initial distance achieved, 
changes were consistent in all groups, although patients with 
the best walking distance at baseline improved the least. 
The multivariable analyses also revealed that women, older 
patients (.75 years), those with MRC =5, and current smok-
ers had significantly less improvement in 6MWD compared to 
reference groups. Relative changes in 6MWD are positively 
correlated to changes in 15D (P=0.016), as shown in Figure 1.
The HRQoL and 15D improved by a score of 0.03 
(P,0.001), which is considered to be clinically relevant. The 
analyses showed that the individuals with the lowest 15D at 
baseline on average improved the most on the relative scale 
Table 2 Multivariate linear regression models of the effect of Pr on 6MWD at the end of the program adjusted for baseline 6MWD, 
gender, age, FeV1, BMI, pack-years, COPD stage, MrC, and smoking status
Improvement in the 6MWD after pulmonary rehabilitation
Variables 95% CI P-value
6MWD mean change m (sD) 445.0 (151.0)–400.0 (132.5) (n=579) [38.0–46.0] ,0.001
6MWD at baseline, m [22–320] (n=88)   
 [321–395] (n=85)   
 [396–463] (n=106)   
 [463–663] (n=94) [−0.18, −0.08] ,0.001
gender Female (n=210)   
 Male (n=163) [0.00, 0.10] 0.04
age (years) [30–62] (n=111)   
 [63–69] (n=112)   
 [70–74] (n=70)   
 [75–90] (n=80) [−0.13, −0.04] 0.02
FeV1  [−0.01, 0.20] 0.55
BMI (kg/m2) [9.16–22.42] (n=76)   
 [22.43–25.70] (n=93)   
 [25.70–29.63] (n=97)   
 [29.64–48.69] (n=107) [−0.04, 0.06] 0.55
Pack-years [0–22.5] (n=103)   
 [22.6–37.5] (n=100)   
 [37.6–50.0] (n=87)   
 [50.1–200.0] (n=83) [−0.01, 0.08] 0.13
COPD gOlD stage Mild (n=27)   
 Moderate (n=199) [−0.11, 0.15]  
 severe (n=117) [−0.05, 0.25]  
 Very severe (n=30) [−0.09, 0.29] 0.30
MrC 1 (n=26)   
 2 (n=127) [−0.14, 0.00]  
 3 (n=164) [−0.15, −0.01]  
 4 (n=39) [−0.21, −0.03]  
 5 (n=7) [−0.34, −0.06] 0.03
smoking status never (n=19) [−0.43, −0.04]  
 ex-smoker (n=253)   
 smoker (n=101) [−0.06, 0.02] 0.05
Abbreviations: BMI, body mass index; MrC, Medical research Council; 6MWD, 6-minute walking distance; Pr, pulmonary rehabilitation.
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(P,0.05). No other factors were associated with changes in 
15D. The positive changes in 15D correlated with the initial 
MRC score such that patients with higher MRC improved 
more in 15D (P=0.042) (Figure 2).
Discussion
Results from this database of community-based PR showed 
statistically significant and clinically meaningful effects of 
the chosen outcomes: exercise capacity measured as 6MWD 
and quality of life measured using the 15D questionnaire. 
The overall magnitude of the effect on 6MWD corresponds 
to “moderate response” to PR as suggested by a Dutch group 
but clearly exceeds the revised minimal clinical important 
difference (MCID) of 30 m for this test.16,17 Furthermore, 
our results are almost identical to other recently published 
studies of community-based multicenter PR from Australia 
and the UK.18,19 The latter study also found that the patients 
with the lowest 6MWD at baseline improved the most and 
that there was no independent association between baseline 
variables and change in HRQoL.19
Table 3 Multivariate linear regression models of the effect of Pr on quality of life (15D) at the end of the program adjusted for 
baseline 15D, gender, age, FeV1, BMI, pack-years, COPD stage, MrC, and smoking status
Improvement in quality of life after pulmonary rehabilitation
Variables 95% CI P-value
15D mean change (IQr) 0.854 (0.121)–0.826 (0.122) (n=558) [0.023, 0.035] ,0.001
15D at baseline [0.43–0.75] (n=72)   
 [0.76–0.82] (n=86)   
 [0.83–0.88] (n=100)   
 [0.88–1.00] (n=99) [−0.10, −0.05] ,0.001
gender Female (n=207)   
 Male (n=150) [−0.04, 0.00] 0.08
age (years) [30–62] (n=96)   
 [63–69] (n=110)   
 [70–74] (n=77)   
 [75–90] (n=74) [−0.03, 0.02] 0.23
FeV1  [−0.05, 0.06] 0.22
BMI (kg/m2) [9.16–22.42] (n=69)   
 [22.43–25.70] (n=84)   
 [25.70–29.63] (n=96)   
 [29.64–48.69] (n=107) [−0.03, 0.02] 0.65
Pack-years [0–22.5] (n=89)   
 [22.6–37.5] (n=96)   
 [37.6–50.0] (n=88)   
 [50.1–200.0] (n=84) [−0.03, 0.01] 0.90
COPD gOlD stage Mild (n=29)   
 Moderate (n=182) [−0.01, 0.12]  
 severe (n=120) [−0.01, 0.15]  
 Very severe (n=26) [−0.02, 0.17] 0.36
MrC 1 (n=18)   
 2 (n=114) [−0.04, 0.04]  
 3 (n=172) [−0.04, 0.04]  
 4 (n=45) [−0.04, 0.06]  
 5 (n=8) [−0.07, 0.08] 0.88
smoking status never (n=19) [−0.12, 0.11]  
 ex-smoker (n=245)   
 smoker (n=93) [−0.02, 0.03] 0.92
Abbreviations: BMI, body mass index; MrC, Medical research Council; Pr, pulmonary rehabilitation. 
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Successful PR in this setting was defined as participation 
in .50% of the sessions and this was achieved by 72% of the 
patients, which we consider is in alignment with and even 
better than current evidence.1,18,19 However, in the London 
study comprising nearly as many patients as in our study, the 
criterion for completion of the PR was at least 75% of the 
visits. The adherence in our study was slightly higher than 
in another study of similar size that included two hospitals 
and five community PR sites.20 It could be hypothesized that 
adherence to a PR program would be better in a community 
setting which, in many countries including Denmark, receives 
patients with less severe disease and is thus at lower risk of 
dropout due to exacerbation.
Baseline characteristics of the patients referred for PR in 
this real-life setting are also comparable to other studies,1 and 
overall the KOALA project also captures those intended for 
community-based PR. Unfortunately, data on GOLD stage 
(and thereby registration of FEV
1
 and FVC) were missing 
for 17% of the participants. Nevertheless, the majority were 
in GOLD stage II and III (moderate and severe COPD). 
It is noteworthy that ~40% of the patients were registered 
as having less dyspnea (MRC 1–2), which at that time was 
considered a “contra-indication” for referral to PR. Due to 
the increasing evidence for the benefit of PR in patients 
with milder disease based on FEV
1
 and/or less symptom 
burden,7,21,22 it is considered appropriate in the new Danish 
guidelines for PR to refer patients with MRC 2, who also 
show signs of muscle depletion.23 While it is generally rec-
ognized that most patients with COPD have one or more 
comorbidities,24 only one in five reported heart disease as 
the most common comorbidity and ~10% reported other 
comorbidities such as depression, diabetes, or osteoporosis. 
Most likely this also reflects the milder disease status in 
this setting.
We have previously shown that most municipalities in 
Denmark quickly complied with the task of performing PR 
in non-healthcare facilities and that the KOALA database 
was a feasible instrument for data recording.11 Now the 
efficacy results of the standardized training have proven to 
be in accordance with the above-mentioned evidence, which 
has emerged during the recent years, and the outcomes are 
favorable and comparable to hospital-based PR in terms of 
exercise capacity and quality of life.
strengths and limitations
A strength of the present study is that it reflects current 
clinical practice and thus has greater relevance than the 
selected populations normally recruited to clinical trials. 
This is, however, also a weakness, since the results cannot 
be confirmed by comparison with a control group. However, 
it is now generally recognized that it would be unethical to 
allocate patients in need of PR to a control group without 
such intervention. The large number of participants, inclusion 
of many centers, and application of the KOALA database 
also contribute to the external validity of the study. Limita-
tions are we have no data on further follow-up visits after 
completion of rehabilitation program, no registration of 
??? ??? ??? ? ?? ?? ?????
???
???
?????????? ???????????????????????????????
???????????????
??????
Figure 1 relative improvement in 6MWD vs relative improvement in 15D.
Note: The solid black line is the fitted regression line and the red dashed lines are 
95% confidence bands (P=0.016).
Abbreviations: 15D, 15-item questionnaire; 6MWD, 6-minute walking distance.
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Figure 2 spearman rank correlation for relative improvement of 15D and correlated 
to MrC at visit 1 (baseline).
Note: R=0.088, P=0.042, n=530.
Abbreviations: 15D, 15-item questionnaire; MrC, Medical research Council.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
5.
17
8.
2 
on
 1
6-
Ju
l-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2019:14 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
99
effects of community-based Pr in 33 municipalities in Denmark
healthcare utilization, some missing data on lung function 
measurements, and no recording of reasons for dropout 
during the PR. Furthermore, more than half of the approached 
healthcare centers/PR facilities declined to use the KOALA 
database, the most common reasons being that they already 
had a registration tool or that they did not want to cooperate 
with the pharmaceutical industry as previously described.9 
Another potential source of bias comes from the fact that 
some small municipalities deliver generic PR, meaning that 
the physical training sessions are performed together with 
patients suffering from other chronic conditions such as heart 
failure or musculoskeletal disorders. This would, however, 
tend to dilute the efficacy parameters and thus underestimate 
the results.
Conclusion
We conclude that pulmonary rehabilitation is effective when 
conducted in community-based facilities and that a significant 
improvement in walking distance of 45 m is similar to current 
knowledge regarding PR in a less intensive setting. There is 
also a positive effect on HRQoL, which is most pronounced 
in patients with the largest baseline symptom burden.
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